The role of secondary cytoreductive surgery for recurrent ovarian cancer

Gungor M., Ortac F., Arvas M., Kosebay D., Sonmezer M., Kose K.

GYNECOLOGIC ONCOLOGY, cilt.97, sa.1, ss.74-79, 2005 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 97 Sayı: 1
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1016/j.ygyno.2004.11.057
  • Dergi Adı: GYNECOLOGIC ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.74-79
  • Anahtar Kelimeler: recurrent ovarian cancer, secondary cytoreduction, chemotherapy, prognosis, DEBULKING SURGERY, CARCINOMA, CISPLATIN, SURVIVAL, THERAPY
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective. The aim of this study was to assess the survival benefit of salvage surgical cytoreduction in patients with recurrent ovarian cancer and compare the surgical outcorne with salvage chemotherapy alone.